These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10364771)

  • 21. [Current problems of antithrombotic therapy].
    Liusov VA; Belousov IuB
    Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
    [No Abstract]   [Full Text] [Related]  

  • 22. Perspectives: fibrinolysis and thrombolysis.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1966; 20():1-12. PubMed ID: 5973051
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of venous thromboembolic disorders: new challenges and opportunities.
    Prandoni P
    Haematologica; 2003 Jun; 88(6):610-3. PubMed ID: 12801835
    [No Abstract]   [Full Text] [Related]  

  • 24. Antithrombotic agents in coronary artery disease.
    Cairns JA; Lewis HD; Meade TW; Sutton GC; Théroux P
    Chest; 1995 Oct; 108(4 Suppl):380S-400S. PubMed ID: 7555191
    [No Abstract]   [Full Text] [Related]  

  • 25. Thromboembolism.
    Fitzmaurice D; Hobbs FR; McManus R
    Clin Evid; 2005 Dec; (14):198-215. PubMed ID: 16620405
    [No Abstract]   [Full Text] [Related]  

  • 26. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.
    Andreotti F; Rocca B; Husted S; Ajjan RA; ten Berg J; Cattaneo M; Collet JP; De Caterina R; Fox KA; Halvorsen S; Huber K; Hylek EM; Lip GY; Montalescot G; Morais J; Patrono C; Verheugt FW; Wallentin L; Weiss TW; Storey RF;
    Eur Heart J; 2015 Dec; 36(46):3238-49. PubMed ID: 26163482
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiology patient pages. Treatment of blood clots.
    Goldhaber SZ; Grasso-Correnti N
    Circulation; 2002 Nov; 106(20):e138-40. PubMed ID: 12427663
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy.
    White CW
    Circulation; 1989 Nov; 80(5):1482-5. PubMed ID: 2805279
    [No Abstract]   [Full Text] [Related]  

  • 29. New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction?
    Liew A; Piran S; Douketis J
    Intern Emerg Med; 2015 Jun; 10(4):493-8. PubMed ID: 25820762
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for anticoagulation therapy for venous thromboembolism.
    Cundiff DK
    J Gen Intern Med; 2002 Jan; 17(1):85. PubMed ID: 11903782
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current data on diagnosis and treatment of thromboembolic states].
    Zosin P; Roth L
    Med Interna (Bucur); 1972 Aug; 24(8):947-58. PubMed ID: 5080893
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on the guidelines for the management of ST-elevation myocardial infarction.
    Levisman J; Price MJ
    Am J Cardiol; 2015 Mar; 115(5 Suppl):3A-9A. PubMed ID: 25728973
    [No Abstract]   [Full Text] [Related]  

  • 34. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin as an emergency drug.
    Wynn RL
    Gen Dent; 2009; 57(5):464-6. PubMed ID: 19903635
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current use of anti-hemostatics in ischemic cardiopathy].
    Bolao IG; Alegría E; Iglesias I; Velasco S; Fidalgo ML; Gómez JA; Huelmos A
    Rev Med Univ Navarra; 1990; 34(4):219-26. PubMed ID: 2152748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correction of thrombophilia].
    Caruzzo C; Marcolongo M; Arpino E; Di Summa M
    Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular drugs in the new millennium.
    Frangos SG; Chen AH; Sumpio B
    J Am Coll Surg; 2000 Jul; 191(1):76-92. PubMed ID: 10898187
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 40. Tinzaparin in the treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Expert Opin Pharmacother; 2003 Dec; 4(12):2355-62. PubMed ID: 14640933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.